Evidence map›Paper›PMID 40484967›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

Prognostic value of early post-treatment

Seyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, Claudia Ortega, Ur Metser, David Hodgson, Robert Kridel, Christine Chen, Sita Bhella, Kelly Yuen Wai Chin and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Review
  5. Predictive value of maximum tumor dissemination (Dmax) in lymphoma patients treated with CD19-specific CAR T-Cells.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seyed Ali MirshahvaladJoint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital, University of Toronto, Toronto, ON, Canada. ali.mirshahvalad@uhn.ca.ORCID http://orcid.org/0000-0003-2271-9764
Andres KohanJoint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital, University of Toronto, Toronto, ON, Canada.
Roshini KulanthaiveluJoint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital, University of Toronto, Toronto, ON, Canada.
Claudia OrtegaJoint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital, University of Toronto, Toronto, ON, Canada.
Ur MetserJoint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital, University of Toronto, Toronto, ON, Canada.
David HodgsonMedical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Robert KridelMedical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Christine ChenMedical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Sita BhellaMedical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Kelly Yuen Wai ChinMedical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Patrick Veit-HaibachJoint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital, University of Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the prognostic value of early post-treatment

methodsIn this retrospective study, 159 patients referred for imaging prior to CAR-T therapy between January 2018 and May 2023 were reviewed. Of those, 51 with both baseline pre-infusion and one-month post-treatment

resultsOverall, 51 patients (mean age = 56y) entered the study. All had Deauville scores of 4 (14/51; 28%) or 5 (37/51; 72%) at baseline. At one month, 28% of patients showed a complete metabolic response, while 72% had

conclusionEarly post-treatment

Indexed as

Immunotherapy, AdoptiveLymphoma, Large B-Cell, DiffusePositron Emission Tomography Computed TomographyAdultAgedFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedPrognosisRadiopharmaceuticalsReceptors, Chimeric AntigenRetrospective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsReceptors, Chimeric AntigenChimeric antigen receptorFluorodeoxyglucoseLymphomaPositron emission tomographyPrognosisSurvival

Identifiers

PMID40484967
PMCPMC12147336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.